We aim to treat patients suffering from chronic inflammatory respiratory diseases, including asthma, with a therapy that surpasses the existing standard of care.
BIOLOGYBasic science
testo da scrivere
IMMUNOLOGYClinical immunology Research
testo da scrivere
RESULTSIt’s personal
We are dedicated to providing quality treatment for chronic diseases.
ABOUT USOver 20 Years of Experience. We'll Ensure You Always Get the Best Possible Results
Our processes will be tailored to best fit your needs, and we will assist you by answering your questions and helping to define your goals.
We propose a new therapeutic approach with disease-modifying potential: treating patients with asthma with autologous monocyte-derived Macrophages (Macs) in which PLA2G5 has been removed using CRISPR technology.